For many healthcare professionals, the focus is either clinical practice or business. For pharmacist and healthcare strategist Ebiuwa Emokpae, the two have become inseparable.

His career has taken him from hospital pharmacy and public healthcare administration in Nigeria to pharmaceutical commercial strategy in the United States. Across both healthcare systems, one objective has remained consistent: improving how medicines reach the people who need them.

Emokpae began his professional journey at the University of Benin Teaching Hospital, where he gained first-hand experience in medication management, pharmaceutical supply and hospital operations. Working within a busy tertiary healthcare environment exposed him to the consequences of medicine shortages, supply chain disruptions and the operational challenges that often determine whether patients receive timely treatment.

“That experience taught me that developing effective medicines is only part of the solution,” Emokpae said. “Patients also need healthcare systems capable of delivering those medicines efficiently.”

His experience later expanded into public-sector healthcare administration, providing a broader understanding of healthcare delivery before he transitioned into the multinational pharmaceutical industry.

Working across therapeutic areas including neuroscience, ophthalmology and infectious diseases, Emokpae became involved in product commercialisation, market development, physician engagement and patient access programmes. The role offered a different perspective on healthcare delivery, highlighting that access to treatment depends not only on scientific innovation but also on pricing, reimbursement, healthcare policy, physician education and distribution systems.

Alongside his commercial responsibilities, he became actively involved in health education initiatives aimed at improving awareness of conditions that often receive limited public attention.

Working with the Medical Women’s Association of Nigeria, he participated in educational programmes focused on women’s health, while also supporting epilepsy awareness campaigns through radio, television and digital media. His public engagement sought to challenge misconceptions surrounding epilepsy and encourage greater understanding of the condition as a manageable neurological disorder.

He also organised webinars and professional conferences for healthcare practitioners and policymakers to encourage greater collaboration on disease management and patient care. One of the webinars attracted more than 300 participants, providing a platform for discussions on clinical practice, healthcare policy and improving treatment access.

“Access is influenced by many factors,” he said. “Sometimes the biggest obstacle is not the availability of medicine but limited awareness, stigma or the absence of coordinated healthcare delivery.”

The COVID-19 pandemic further reinforced those lessons. As pharmaceutical supply chains came under unprecedented pressure, Emokpae worked on forecasting demand and adapting distribution strategies to help maintain medicine availability during a period of global disruption.

Seeking to complement his healthcare background with broader business expertise, he completed a Master of Business Administration at Northwestern University’s Kellogg School of Management, concentrating in marketing, strategy and management analytics.

He said the programme strengthened his understanding of business strategy, organisational decision-making and data-driven planning, skills that increasingly shape modern pharmaceutical operations.

“My pharmacy training taught me to think about medicines and patients,” he explained. “Business education broadened that perspective to include markets, organisations, data and the many stakeholders whose decisions influence healthcare access.”

Since relocating to the United States, Emokpae has continued working at the intersection of healthcare and business, contributing to biotechnology and pharmaceutical strategy across areas including market assessment, pricing, commercial analytics, product launch planning and go-to-market strategy.

Rather than viewing healthcare delivery, commercial operations and pharmaceutical supply as separate disciplines, he believes they function best when aligned around a common objective of improving patient outcomes.

That philosophy continues to shape his work as he focuses on strategies that connect commercial execution, healthcare delivery, supply-chain performance and market access.

From hospital pharmacy in Nigeria to pharmaceutical strategy in the United States, Emokpae’s career reflects the growing importance of professionals who understand both the scientific and commercial dimensions of healthcare. As medicines become increasingly sophisticated, he believes ensuring that patients can actually access them remains one of healthcare’s most important challenges.